E

EXIT071

3 employees

EXIT071 develops technology for the analysis of biomarkers exosomes that send messages to other cells.

Basic info

Industry

research services

Sectors

Biotechnology
Therapeutics
Pharmaceutical
Biopharma

Date founded

2021

Funding rounds raised

Total raised

$397K

from 2 investors over 2 rounds

E

EXIT071 raised $397K on February 15, 2022

Investors: Libertatis Ergo Holding B.V. and UNIIQ - Finance for the Future

FAQ